Works by Yoon, Dok Hyun


Results: 149
    1
    2
    3
    4
    5

    A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer.

    Published in:
    Oncologist, 2015, v. 20, n. 10, p. 1119, doi. 10.1634/theoncologist.2015-0208
    By:
    • Lee, Keun‐Wook;
    • Koh, Youngil;
    • Kim, Sung‐Bae;
    • Shin, Sang‐Won;
    • Kang, Jin‐Hyoung;
    • Wu, Hong‐Gyun;
    • Sung, Myung‐Whun;
    • Keam, Bhumsuk;
    • Kim, Dong‐Wan;
    • Kim, Tae Min;
    • Kim, Kwang Hyun;
    • Kwon, Tack‐Kyun;
    • Hah, J. Hun;
    • Kim, In‐Ah;
    • Ahn, Soon‐Hyun;
    • Yoon, Dok Hyun;
    • Lee, Sang‐Wook;
    • Kim, Sang Yoon;
    • Nam, Soon Yuhl;
    • Jung, Kwang‐Yoon
    Publication type:
    Article
    6
    7

    Assessing the Efficacy of Bortezomib and Dexamethasone for Induction and Maintenance Therapy in Relapsed/Refractory Cutaneous T-Cell Lymphoma: A Phase II CISL1701/BIC Study.

    Published in:
    Cancer Research & Treatment, 2025, v. 57, n. 1, p. 267, doi. 10.4143/crt.2024.479
    By:
    • Choi, Yoon Seok;
    • Shim, Joonho;
    • Kang, Ka-Won;
    • Yoon, Sang Eun;
    • Hong, Jun Sik;
    • Lim, Sung Nam;
    • Yhim, Ho-Young;
    • Kwon, Jung Hye;
    • Lee, Gyeong-Won;
    • Yang, Deok-Hwan;
    • Oh, Sung Yong;
    • Shin, Ho-Jin;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Hong Ghi;
    • Jeong, Seong Hyun;
    • Kim, Won Seog;
    • Kim, Seok Jin
    Publication type:
    Article
    8
    9

    Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 684, doi. 10.4143/crt.2022.1434
    By:
    • Hyungwoo Cho;
    • Dok Hyun Yoon;
    • Dong-Yeop Shin;
    • Youngil Koh;
    • Sung-Soo Yoon;
    • Seok Jin Kim;
    • Young Rok Do;
    • Gyeong-Won Lee;
    • Jae-Yong Kwak;
    • Yong Park;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Kwai Han Yoo;
    • Won Sik Lee;
    • Byeong Bae Park;
    • Jae Cheol Jo;
    • Hyeon-Seok Eom;
    • Hyo Jung Kim;
    • Seong Hyun Jeong
    Publication type:
    Article
    10
    11

    Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.

    Published in:
    Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1268, doi. 10.4143/crt.2021.1168
    By:
    • Seong Hyun Jeong;
    • Seok Jin Kim;
    • Dok Hyun Yoon;
    • Yong Park;
    • Hye Jin Kang;
    • Youngil Koh;
    • Gyeong-Won Lee;
    • Won-Sik Lee;
    • Deok-Hwan Yang;
    • Young Rok Do;
    • Min Kyoung Kim;
    • Kwai Han Yoo;
    • Yoon Seok Choi;
    • Hwan Jung Yun;
    • Jun Ho Yi;
    • Jae-Cheol Jo;
    • Hyeon-Seok Eom;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Byeong Bae Park
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.

    Published in:
    International Journal of Hematology, 2021, v. 113, n. 1, p. 81, doi. 10.1007/s12185-020-02988-6
    By:
    • Lee, Ho Sup;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Yoojin;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Jo, Jae-Cheol;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Kim, Sung-Hyun;
    • Kim, Min Kyoung;
    • Lim, Sung-Nam
    Publication type:
    Article
    27
    28
    29

    A Randomized Feasibility Study of <sup>18</sup>F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2017, v. 58, n. 4, p. 563, doi. 10.2967/jnumed.116.178368
    By:
    • Sun Young Chae;
    • Sung-Bae Kim;
    • Sei Hyun Ahn;
    • Hye Ok Kim;
    • Dok Hyun Yoon;
    • Jin-Hee Ahn;
    • Kyung Hae Jung;
    • Sangwon Han;
    • Seung Jun Oh;
    • Sang Ju Lee;
    • Hee Jeong Kim;
    • Byung Ho Son;
    • Gyungyub Gong;
    • Hyo Sang Lee;
    • Dae Hyuk Moon
    Publication type:
    Article
    30
    31

    Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 4, p. 413, doi. 10.1002/ajh.25726
    By:
    • Ho Sup Lee;
    • Kihyun Kim;
    • Seok Jin Kim;
    • Je-Jung Lee;
    • Inho Kim;
    • Jin Seok Kim;
    • Hyeon-Seok Eom;
    • Dok Hyun Yoon;
    • Cheolwon Suh;
    • Ho-Jin Shin;
    • Yeung-Chul Mun;
    • Min Kyoung Kim;
    • Sung-Nam Lim;
    • Chul Won Choi;
    • Hye Jin Kang;
    • Sung-Soo Yoon;
    • Chang-Ki Min
    Publication type:
    Article
    32

    Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1280, doi. 10.1002/ajh.24891
    By:
    • Cho, Hyungwoo;
    • Yoon, Dok Hyun;
    • Lee, Jung Bok;
    • Kim, Sung-Yong;
    • Moon, Joon Ho;
    • Do, Young Rok;
    • Lee, Jae Hoon;
    • Park, Yong;
    • Lee, Ho Sup;
    • Eom, Hyeon Seok;
    • Shin, Ho-Jin;
    • Min, Chang-Ki;
    • Kim, Jin Seok;
    • Jo, Jae-Cheol;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Lee, Won Sik;
    • Lee, Je-Jung;
    • Suh, Cheolwon;
    • Kim, Kihyun
    Publication type:
    Article
    33
    34

    Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.

    Published in:
    Cancer Medicine, 2017, v. 6, n. 1, p. 100, doi. 10.1002/cam4.970
    By:
    • Kwon, Jihyun;
    • Min, Chang‐Ki;
    • Kim, Kihyun;
    • Han, Jae‐joon;
    • Moon, Joon Ho;
    • Kang, Hye Jin;
    • Eom, Hyeon‐Seok;
    • Kim, Min Kyoung;
    • Kim, Hyo Jung;
    • Yoon, Dok Hyun;
    • Lee, Jeong‐Ok;
    • Lee, Won Sik;
    • Lee, Jae Hoon;
    • Lee, Je‐Jung;
    • Choi, Yoon‐seok;
    • Kim, Sung hyun;
    • Yoon, Sung‐soo
    Publication type:
    Article
    35
    36
    37
    38
    39

    Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 655, doi. 10.1007/s00280-011-1750-5
    By:
    • Koo, Dong;
    • Park, Seung-Il;
    • Kim, Yong-Hee;
    • Kim, Jong;
    • Jung, Hwoon-Yong;
    • Lee, Gin-Hyug;
    • Choi, Kee;
    • Song, Ho;
    • Shin, Ji;
    • Cho, Kyung-Ja;
    • Yoon, Dok-Hyun;
    • Kim, Sung-Bae
    Publication type:
    Article
    40

    Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202).

    Published in:
    HemaSphere, 2024, v. 8, n. 1, p. 1, doi. 10.1002/hem3.33
    By:
    • Hyungwoo Cho;
    • Kihyun Kim;
    • Sang Eun Yoon;
    • Sung-Hoon Jung;
    • Je-Jung Lee;
    • Joon Ho Moon;
    • Hee Jeong Cho;
    • Ho Sup Lee;
    • Ka-Won Kang;
    • Sung-Yong Kim;
    • Hyeon-Seok Eom;
    • Yeung-Chul Mun;
    • Young Hoon Park;
    • Sung-Soo Yoon;
    • Young Rok Do;
    • Won Sik Lee;
    • Chang-Ki Min;
    • Dok Hyun Yoon
    Publication type:
    Article
    41
    42

    S224: HIGH COMPLETE RESPONSE RATE WITH TNB‐486, A NOVEL CD19XCD3 T‐CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967808.60614.fc
    By:
    • Jacobs, Ryan;
    • Nair, Ranjit;
    • Cho, Seok‐Goo;
    • Devata, Sumana;
    • Gaballa, Sameh;
    • Yoon, Dok Hyun;
    • Stevens, Don;
    • Kim, Jin Seok;
    • Shah, Nirav N;
    • Brennan, Denise Marie;
    • Law, Jason;
    • Lesley, Robin;
    • Chen, Rob;
    • Forcina, Alessandra;
    • Buelow, Ben;
    • Hou, Jing‐Zhou
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 6, p. 1406, doi. 10.3109/10428194.2015.1099650
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Jin Seok;
    • Chae, Yee Soo;
    • Lee, Gyeong-Won;
    • Eom, Hyeon Seok;
    • Ryoo, Hun Mo;
    • Lee, Suee;
    • Kim, Seok Jin;
    • Yoon, Dok Hyun;
    • Won, Jong Ho;
    • Hong, Junshik;
    • Park, Jinny;
    • Lee, Sang-Min;
    • Hong, Jung Yong;
    • Park, Eunkyung;
    • Kim, Hyo Jung;
    • Yang, Deok-Hwan;
    • Kim, Hyo-Jin;
    • Suh, Cheolwon
    Publication type:
    Article
    49
    50